Materials today. Bio · 2026
Stage-specific MSC spheroid fusion enables bottom-up formation of stage-defined hierarchical cartilage graft.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Yen-Liang, Lin Yun-Chieh, Tsai Yi-Chen, Yen Chun-Che, Chiang Chun-Yi, Hung Pen-Jung, Huang Yu-Ting, Chang Chih-Hung, Lin Feng-Huei, Liu Hwa-Chang
Аннотация
Engineering articular cartilage with hierarchical architecture and effective interfacial integration remains a major challenge. Although bottom-up spheroid assembly offers a promising biofabrication strategy, how chondrogenic maturation influences spheroid fusion and boundary remodeling remains incompletely defined. Here, we investigated differentiation stage as a programmable determinant of the phenotype and assembly behavior of mesenchymal stem cell (MSC)-derived chondrogenic spheroids. Exploratory RNA-seq pathway mapping, complemented by biologically replicated RT-qPCR, indicated stage- and cell-source-associated differences in cartilage matrix and maturation-related programs in bone marrow-derived MSCs (BM-MSCs) and umbilical cord-derived MSCs (UC-MSCs). Early-stage spheroids exhibited greater fusion capacity than mature spheroids, whereas incorporation of undifferentiated MSCs promoted the integration of mature chondrogenic spheroids and reduced persistent inter-spheroid boundaries. Sequential assembly of Day-3, Day-7, and Day-14 spheroids generated hierarchical constructs with stage-associated regional differences in cartilage extracellular matrix deposition. Incorporating an undifferentiated MSC layer at the bone-facing interface further supported structural continuity with a porous bone substitute in vitro. In an exploratory porcine pilot study involving two animals, implantation of MSC-derived spheroid grafts into cartilage defects was technically feasible. At 6 months, the repair tissue exhibited variable proteoglycan staining and heterogeneous collagen type II immunoreactivity, while selected sections showed tissue apposition at the graft-host interface. The limited animal-level sample size precluded conclusions regarding repair efficacy, cartilage quality, or superiority over autologous cartilage implantation. Collectively, these findings identify differentiation stage as an intrinsic bioassembly variable and establish a stage-programmed strategy for constructing hierarchical cartilage grafts. Both BM-MSCs and UC-MSCs supported stage-defined assembly in vitro, warranting further evaluation of UC-MSCs as a potential allogeneic cell source in adequately powered studies.